Pfizer
Strata Oncology, Pfizer Partner to Explore New Biomarker Indications for FDA-Approved Drugs
Pfizer is the first drugmaker to join the Strata PATH platform trial and will contribute drugs to advanced cancer patients in four study arms.
Nonprofit Friends of Cancer Research Launches Public-Private HRD Harmonization Project
The consortium aims to harmonize the use of homologous recombination deficiency as a biomarker to guide certain treatment types in cancer patients.
UK Biobank Collaborating With Biopharmas to Profile Plasma Proteome of 53K Subjects
Led by a group of 10 biopharmaceutical firms, the project will use Olink's proteomic technology to look at participants' plasma levels of roughly 1,500 proteins.
Opko Health Q3 Revenues Up 87 Percent
The firm's subsidiary BioReference Laboratories performed 3.5 million COVID-19 PCR tests and 300,000 serology tests during the quarter.
Roche EGFR Mutation Test Approved by FDA as Companion Diagnostic for NSCLC
Roche's real-time PCR test detects defined mutations of the epidermal growth factor receptor gene in DNA from non-small cell lung cancer patients.
Jun 4, 2019
Apr 30, 2019
Exact Sciences Q1 Revenues Up 79 Percent
Oct 30, 2018
Exact Sciences Q3 Revenues Up 63 Percent
Oct 30, 2018
Precision Oncology Highlights From ESMO 2018
Oct 12, 2018
AmoyDx Lung Cancer CDx Approved in South Korea
Aug 22, 2018